Fundamental Analysis of RICEBRAN TECHNOLOGIES(NASDAQ:RIBT) stock

Fundamental Rating

RIBT gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 92 industry peers in the Food Products industry. RIBT may be in some trouble as it scores bad on both profitability and health. RIBT does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year RIBT has reported negative net income.

In the past year RIBT has reported a negative cash flow from operations.

In the past 5 years RIBT always reported negative net income.

In the past 5 years RIBT always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -141.05%, RIBT is doing worse than 95.70% of the companies in the same industry.

Looking at the Return On Equity, with a value of -1786.67%, RIBT is doing worse than 94.62% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-141.05%
ROE	-1786.67%
ROIC	N/A

ROA(3y)-30.33%

ROA(5y)-30.36%

ROE(3y)-53.15%

ROE(5y)-47.52%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

RIBT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

RIBT does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for RIBT has been increased compared to 1 year ago.

RIBT has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, RIBT has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -39.85, we must say that RIBT is in the distress zone and has some risk of bankruptcy.

RIBT has a worse Altman-Z score (-39.85) than 97.85% of its industry peers.

A Debt/Equity ratio of 3.78 is on the high side and indicates that RIBT has dependencies on debt financing.

RIBT has a Debt to Equity ratio of 3.78. This is amonst the worse of the industry: RIBT underperforms 93.55% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	3.78
Debt/FCF	N/A
Altman-Z	-39.85

ROIC/WACCN/A

WACC7.79%

2.3 Liquidity

A Current Ratio of 0.51 indicates that RIBT may have some problems paying its short term obligations.

With a Current ratio value of 0.51, RIBT is not doing good in the industry: 94.62% of the companies in the same industry are doing better.

A Quick Ratio of 0.45 indicates that RIBT may have some problems paying its short term obligations.

RIBT has a worse Quick ratio (0.45) than 84.95% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.51
Quick Ratio	0.45

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for RIBT have decreased by -8.77% in the last year.

The Revenue has grown by 19.84% in the past year. This is quite good.

RIBT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.52% yearly.

EPS 1Y (TTM)-8.77%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-212.24%

Revenue 1Y (TTM)19.84%

Revenue growth 3Y20.63%

Revenue growth 5Y25.52%

Revenue growth Q2Q-4.71%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RIBT. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

RIBT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

RICEBRAN TECHNOLOGIES

NASDAQ:RIBT (11/7/2023, 7:20:17 PM)

After market: 0.3675 +0.02 (+5%)

0.35

-0.01 (-1.69%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupFood, Beverage & Tobacco

GICS IndustryFood Products

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap2.31M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-141.05%
ROE	-1786.67%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover2.89

Health

		Industry Rank	Sector Rank
Debt/Equity	3.78
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.51
Quick Ratio	0.45
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-8.77%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)19.84%

Revenue growth 3Y20.63%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

RICEBRAN TECHNOLOGIES (RIBT)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens